Clover Health officer proposes $72.3K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clover Health Investments, Corp. (CLOV) officer Joseph Clay Thornton reported a proposed sale of 16,942 Class A common shares, with an aggregate market value of $72,342.34 and an approximate sale date of August 17, 2026. The sale is described as intended to cover tax withholding obligations tied to restricted stock unit vesting and settlement, not as a discretionary transaction.
The Rule 10b5-1 plan adoption or instruction date is March 2, 2026. A past-three-month transaction listed for July 15, 2026 was a sale of 4,630 shares for gross proceeds of $21,622.1, identified as a 10b5-1 plan sale.
Key Figures
Key Terms
restricted stock units financial
sell to cover financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.